NEW YORK (GenomeWeb News) – Bruker said today at the 12th annual meeting of the Human Proteome Organization in Yokohama, Japan, that it has launched a second-phase collaboration agreement with SISCAPA Assays Technologies to apply the SISCAPA immunoenrichment mass spec method to its MALDI-TOF instruments.

Through the collaboration, the two firms aim to establish fully automated SISCAPA-MALDI workflows in Bruker's demonstration facilities as well as to develop and validate new protein assays, with a particular focus on assays of relevance to clinical microbiology research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.